Treatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologists

References

• SEER cancer statistics factsheets: acute myeloid leukemia. Bethesda (MD): National Cancer Institute. http://seer.cancer.gov/statfacts/html/amyl.html.
   Google Scholar
• Kantarjian H, O'Brien S, Cortes J, et al. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome. Cancer. 2006;106(5):1090–1098.
   PubMed Web of Science ®Google Scholar
• Löwenberg B, Zittoun R, Kerkhofs H, et al. On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group. J Clin Oncol. 1989;7(9):1268–1274.
   PubMed Web of Science ®Google Scholar
• Kantarjian HM, Thomas XG, Dmoszynska A, et al. Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia. J Clin Oncol. 2012;30(21):2670–2677.
   PubMed Web of Science ®Google Scholar
• Tawfik B, Sliesoraitis S, Lyerly S, et al. Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML). Ann Hematol. 2014;93(1):47–55.
   PubMed Web of Science ®Google Scholar
• Medeiros BC, Satram-Hoang S, Momin F, et al. Real-world treatment patterns and comparative effectiveness among a population of elderly patients with acute myeloid leukemia (AML). Blood. 2018;132(Supplement 1):835–835.
   Google Scholar
• Bhatt VR, Shostrom V, Armitage JO, et al. Treatment patterns and outcomes of octogenarian patients with acute myeloid leukemia. Am J Hematol. 2019;94(6):E169–E172.
   PubMed Web of Science ®Google Scholar
• LeBlanc TW, Walter RB, Hernandez-Aldama L, et al. Treatment decision making in AML: factors of importance to clinicians, AML patients and their family. Blood. 2019;134(Supplement_1):3498–3498.
   Google Scholar
• Richardson DR, Seo J, Smith BD, et al. Quantifying patient preferences for treatment outcomes in AML: a discrete-choice experiment. Blood. 2018;132(Supplement 1):718–718.
   Web of Science ®Google Scholar
• Tariman JD, Doorenbos A, Schepp KG, et al. Patient, physician and contextual factors are influential in the treatment decision making of older adults newly diagnosed with symptomatic myeloma. Cancer Treatment Communications. 2014;2(2–3):34–47.
   PubMedGoogle Scholar
• van der Poel MW, Mulder WJ, Ossenkoppele GJ, et al. Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study. Ann Hematol. 2015;94(8):1373–1379.
   PubMed Web of Science ®Google Scholar
• Mohile SG, Magnuson A, Pandya C, et al. Community oncologists' decision-making for treatment of older patients with cancer. J Natl Compr Canc Netw. 2018;16(3):301–309.
   PubMed Web of Science ®Google Scholar
• George TI, Erba HP, Steensma DP, et al. Current diagnosis patterns for acute myeloid leukemia (AML) in clinical practice compared with World Health Organization (WHO) 2008 recommendations: outcomes from the CONNECT Myelodysplastic Syndromes (MDS) and AML Disease Registry. Blood. 2016;128(22):3548–3548.
   Web of Science ®Google Scholar
• Peditto K. Reporting qualitative research: standards, challenges, and implications for health design. Herd. 2018;11(2):16–19.
   PubMedGoogle Scholar
• Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–357.
   PubMed Web of Science ®Google Scholar
• Desch CE, Blayney DW. Making the choice between academic oncology and community practice: the Big Picture and Details About Each Career. J Oncol Pract. 2006;2(3):132–136.
   PubMedGoogle Scholar
• Zafar SY, Alexander SC, Weinfurt KP, et al. Decision making and quality of life in the treatment of cancer: a review. Supp Care Cancer. 2009;17(2):117–127.
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381.
   PubMed Web of Science ®Google Scholar
• Ando H, Cousins R, Young C. Achieving saturation in thematic analysis: development and refinement of a codebook. Compr Psychol. 2014;3:03.CP.3.4–04.
   Google Scholar
• Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–1288.
   PubMed Web of Science ®Google Scholar
• Sekeres MA, Stone RM, Zahrieh D, et al. Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome. Leukemia. 2004;18(4):809–816.
   PubMed Web of Science ®Google Scholar
• LeBlanc TW. Shared decision-making in acute myeloid leukemia. Semin Oncol Nurs. 2019;35(6):150958
   PubMed Web of Science ®Google Scholar
• Abel GA, Klepin HD. Frailty and the management of hematologic malignancies. Blood. 2018;131(5):515–524.
   PubMed Web of Science ®Google Scholar
• Klepin HD, Estey E, Kadia T. More versus less therapy for older adults with acute myeloid leukemia: new perspectives on an old debate. Am Soc Clin Oncol Educ Book. 2019;39:421–432.
   PubMedGoogle Scholar
• Loh KP, Klepin HD. Geriatric assessment in older patients with acute myeloid leukemia. Cancers. 2018;10(7):225.
   PubMed Web of Science ®Google Scholar
• Molga A, Wall M, Chhetri R, et al. Comprehensive geriatric assessment predicts azacitidine treatment duration and survival in older patients with myelodysplastic syndromes. J Geriatr Oncol. 2020;11(1):114–120.
   PubMed Web of Science ®Google Scholar
• Klepin HD, Geiger AM, Tooze JA, et al. Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia. Blood. 2013;121(21):4287–4294.
   PubMed Web of Science ®Google Scholar
• Deschler B, Ihorst G, Platzbecker U, et al. Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome. Haematologica. 2013;98(2):208–216.
   PubMed Web of Science ®Google Scholar
• Mohile SG, Epstein RM, Hurria A, et al. Communication with older patients with cancer using geriatric assessment: a cluster-randomized clinical trial from the National Cancer Institute Community Oncology Research Program. JAMA Oncol. 2019;6(2):1–9.
   Web of Science ®Google Scholar
• Mohile SG, Velarde C, Hurria A, et al. Geriatric assessment-guided care processes for older adults: a delphi consensus of geriatric oncology experts. J Natl Compr Canc Netw. 2015;13(9):1120–1130.
   PubMed Web of Science ®Google Scholar
• Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29(25):3457–3465.
   PubMed Web of Science ®Google Scholar
• Hurria A, Akiba C, Kim J, et al. Reliability, validity, and feasibility of a computer-based geriatric assessment for older adults with cancer. JOP. 2016;12(12):e1025–e1034.
   PubMedGoogle Scholar
• Nathwani N, Kurtin SE, Lipe B, et al. Integrating touchscreen-based geriatric assessment and frailty screening for adults with multiple myeloma to drive personalized treatment decisions. J Oncol Pract. 2019;16(1):e92–e99.
   Google Scholar
• Bergkvist K, Larsen J, Johansson UB, Mattsson J, et al. Hospital care or home care after allogeneic hematopoietic stem cell transplantation-patients' experiences of care and support. Eur J Oncol Nurs. 2013;17(4):389–395.
   PubMed Web of Science ®Google Scholar
• Shahrokni A, Maggiore RJ, Ghassemzadeh H. New technologies in geriatric oncology care. J Geriatr Oncol. 2018;9(6):687–689.
   PubMed Web of Science ®Google Scholar
• Bolle S, Smets EMA, Hamaker ME, et al. Medical decision making for older patients during multidisciplinary oncology team meetings. J Geriatr Oncol. 2019;10(1):74–83.
   PubMed Web of Science ®Google Scholar
• de Angst IB, Kil PJM, Bangma CH, et al. Should we involve patients more actively? Perspectives of the multidisciplinary team on shared decision-making for older patients with metastatic castration-resistant prostate cancer. J Geriatr Oncol. 2019;10(4):653–658.
   PubMed Web of Science ®Google Scholar
• Shea CM, Teal R, Haynes-Maslow L, et al. Assessing the feasibility of a virtual tumor board program: a case study. J Healthc Manag. 2014;59(3):177–193.
   PubMed Web of Science ®Google Scholar
• Lesslie M, Parikh JR. Implementing a multidisciplinary tumor board in the community practice setting. Diagnostics. 2017;7(4):55.
   Web of Science ®Google Scholar
• Jansen J, Butow PN, van Weert JC, et al. Does age really matter? Recall of information presented to newly referred patients with cancer. J Clin Oncol. 2008;26(33):5450–5457.
   PubMed Web of Science ®Google Scholar
• van Weert JC, Jansen J, Spreeuwenberg PM, et al. Effects of communication skills training and a Question Prompt Sheet to improve communication with older cancer patients: a randomized controlled trial. Crit Rev Oncol Hematol. 2011;80(1):145–159.
   PubMed Web of Science ®Google Scholar
• McCarthy DM, Waite KR, Curtis LM, et al. What did the doctor say? Health literacy and recall of medical instructions. Med Care. 2012;50:277–282.
   PubMed Web of Science ®Google Scholar
• Elwyn G, Durand MA, Song J, et al. A three-talk model for shared decision making: multistage consultation process. Bmj. 2017;359:j4891.
   PubMed Web of Science ®Google Scholar
• Schnitzler L, Smith SK, Shepherd HL, et al. Communication during radiation therapy education sessions: the role of medical jargon and emotional support in clarifying patient confusion. Patient Educ Couns. 2017;100(1):112–120.
   PubMed Web of Science ®Google Scholar
• Mandelblatt JS, Edge SB, Meropol NJ, et al. Predictors of long-term outcomes in older breast cancer survivors: perceptions versus patterns of care. J Clin Oncol. 2003;21(5):855–863.
   PubMed Web of Science ®Google Scholar
• Gattellari M, Butow PN, Tattersall MH. Sharing decisions in cancer care. Soc Sci Med. 2001;52(12):1865–1878.
   PubMed Web of Science ®Google Scholar
• Lai C, Doucette K, Norsworthy K. Recent drug approvals for acute myeloid leukemia. J Hematol Oncol. 2019;12(1):100.
   PubMed Web of Science ®Google Scholar
• Abdallah M, Xie Z, Ready A, et al. Management of acute myeloid leukemia (AML) in older patients. Curr Oncol Rep. 2020;22(10):103.
   Web of Science ®Google Scholar
• Hauber AB, Gonzalez JM, Groothuis-Oudshoorn CG, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis Good Research Practices Task Force. Value Health. 2016;19(4):300–315.
   PubMed Web of Science ®Google Scholar
• Wilson L, Loucks A, Bui C, et al. Patient centered decision making: use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices. J Neurol Sci. 2014;344(1–2):80–87.
   PubMed Web of Science ®Google Scholar
• Wei AH, Montesinos P, Ivanov V, et al. Venetoclax plus LDAC for patients with untreated AML ineligible for intensive chemotherapy: phase 3 randomized placebo-controlled trial. Blood. 2020;135(24):2137–2145.
   PubMed Web of Science ®Google Scholar
• DiNardo CD, Pratz K, Pullarkat V, et al. Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. Blood. 2019;133(1):7–17.
   PubMed Web of Science ®Google Scholar
• Glatzer M, Panje CM, Siren C, et al. Treatment options in oncology. Oncology. 2018;2:1–9.
   Google Scholar